Mpox Resurgence: What the Latest Cases Signal for 2026 and Beyond
Health officials in Natal, Brazil, have confirmed the first case of mpox in the city for 2026, alongside four total notifications – one confirmed, two suspected, and one discarded. This development, while currently considered within normal patterns, raises questions about the potential for wider mpox activity as we move further into the year.
Global Mpox Landscape: A Two-Clade Picture
The global mpox situation is complex, characterized by two distinct clades: Clade I and Clade II. As of February 13, 2026, over 46,000 cases of Clade I mpox have been linked to outbreaks in Central and Eastern Africa. Clade II continues to circulate worldwide at lower levels. The CDC reports 11 recent U.S. Cases of Clade I linked to travel to affected areas in Africa, with a concerning emergence of three cases in individuals with no recent travel history, suggesting some local transmission.
The Americas: A Regional Overview
Between 2022 and January 31, 2026, a total of 179,612 confirmed mpox cases have been reported globally, with the Region of the Americas accounting for the largest proportion (41%). Within the Americas, 73,641 confirmed cases, including 160 deaths, were reported in 31 countries and territories. In 2026, eight countries – Argentina, Bolivia, Brazil, Canada, Chile, Colombia, Mexico, and the United States – have reported 172 cases. Notably, two imported Clade Ib cases have been confirmed in the Americas (Mexico and Brazil) among travelers with pre-travel exposure.
Recombinant Viruses and Evolving Strains
Recent research highlights the evolving nature of the mpox virus. The World Health Organization (WHO) reported a case in India of a recombinant virus containing genomic elements of both Clade Ib and IIb, signaling potential for new viral variants. This underscores the need for continued genomic surveillance to track viral evolution and inform public health strategies.
Symptoms and Transmission: What to Watch For
Mpox is transmitted through contact with an infected animal or person, or with materials contaminated with the virus. Symptoms typically include fever, headache, body aches, chills, weakness, and swollen lymph nodes. Characteristic skin eruptions or lesions that progress to scabs are also common. Individuals experiencing these symptoms are advised to seek medical attention at a local health center.
Vaccination and Prevention Efforts
Vaccination remains a crucial tool in preventing mpox. In Natal, Brazil, vaccination is currently available for prioritized groups, including individuals over 18 living with HIV/AIDS and healthcare professionals directly working with the virus. Public health officials emphasize the importance of isolation for suspected or confirmed cases and avoiding the sharing of personal items.
Natal’s Experience: A Local Perspective
Natal first identified a case of mpox in June 2022 in a traveler returning from Europe. Between 2022 and the end of 2025, the city recorded 100 confirmed cases, 176 discarded cases, and no deaths. Local health authorities are continuing to monitor the situation and implement control measures aligned with national guidelines.
FAQ: Mpox in 2026
Q: Is mpox a serious threat?
A: While most cases are mild to moderate, mpox can cause severe illness, particularly in individuals with weakened immune systems.
Q: How is mpox diagnosed?
A: Diagnosis is confirmed through laboratory tests, including molecular testing or genetic sequencing, ordered by a healthcare professional.
Q: What should I do if I suspect I have mpox?
A: Seek medical attention immediately and isolate yourself to prevent potential spread.
Q: Is there a vaccine for mpox?
A: Yes, vaccines are available for prioritized groups. Check with your local health authority for eligibility.
Q: What is the difference between Clade I and Clade II mpox?
A: Both clades can be spread, treated, and prevented in similar ways. Clade I is currently associated with outbreaks in Central and Eastern Africa, while Clade II is circulating globally at lower levels.
Did you know? The mpox virus can survive on surfaces for a limited time, emphasizing the importance of thorough cleaning and disinfection.
Pro Tip: Stay informed about the latest mpox updates from reliable sources like the WHO, CDC, and your local health department.
Stay vigilant, practice good hygiene, and consult with healthcare professionals if you have any concerns. For more information on mpox and ongoing public health efforts, visit the World Health Organization and the Centers for Disease Control and Prevention.
Keep reading